Literature DB >> 21454532

Classification and characterization of therapeutic antibody aggregates.

Marisa K Joubert1, Quanzhou Luo, Yasser Nashed-Samuel, Jette Wypych, Linda O Narhi.   

Abstract

A host of diverse stress techniques was applied to a monoclonal antibody (IgG(2)) to yield protein particles with varying attributes and morphologies. Aggregated solutions were evaluated for percent aggregation, particle counts, size distribution, morphology, changes in secondary and tertiary structure, surface hydrophobicity, metal content, and reversibility. Chemical modifications were also identified in a separate report (Luo, Q., Joubert, M. K., Stevenson, R., Narhi, L. O., and Wypych, J. (2011) J. Biol. Chem. 286, 25134-25144). Aggregates were categorized into seven discrete classes, based on the traits described. Several additional molecules (from the IgG(1) and IgG(2) subtypes as well as intravenous IgG) were stressed and found to be defined with the same classification system. The mechanism of protein aggregation and the type of aggregate formed depends on the nature of the stress applied. Different IgG molecules appear to aggregate by a similar mechanism under the same applied stress. Aggregates created by harsh mechanical stress showed the largest number of subvisible particles, and the class generated by thermal stress displayed the largest number of visible particles. Most classes showed a disruption of the higher order structure, with the degree of disorder depending on the stress process. Particles in all classes (except thermal stress) were at least partially reversible upon dilution in pH 5 buffer. High copper content was detected in isolated metal-catalyzed aggregates, a stress previously shown to produce immunogenic aggregates. In conclusion, protein aggregates can be a very heterogeneous population, whose qualities are the result of the type of stress that was experienced.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454532      PMCID: PMC3137085          DOI: 10.1074/jbc.M110.160457

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Origin, result and measurement of USP "essentially free" inspection for visible contaminating particles.

Authors:  J Z Knapp
Journal:  PDA J Pharm Sci Technol       Date:  2000 May-Jun

2.  Analysis of DNA-protein interactions by intrinsic fluorescence.

Authors:  M L Carpenter; A W Oliver; G G Kneale
Journal:  Methods Mol Biol       Date:  2001

3.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

Review 4.  Colloidal behavior of proteins: effects of the second virial coefficient on solubility, crystallization and aggregation of proteins in aqueous solution.

Authors:  Joseph J Valente; Robert W Payne; Mark Cornell Manning; W William Wilson; Charles S Henry
Journal:  Curr Pharm Biotechnol       Date:  2005-12       Impact factor: 2.837

5.  Structural and functional changes in ultrasonicated bovine serum albumin solutions.

Authors:  Ibrahim Gülseren; Demet Güzey; Barry D Bruce; Jochen Weiss
Journal:  Ultrason Sonochem       Date:  2006-09-07       Impact factor: 7.491

Review 6.  Immunogenicity of biopharmaceuticals.

Authors:  Michele Kessler; David Goldsmith; Huub Schellekens
Journal:  Nephrol Dial Transplant       Date:  2006-10       Impact factor: 5.992

Review 7.  Immunogenicity of protein therapeutics.

Authors:  Anne S De Groot; David W Scott
Journal:  Trends Immunol       Date:  2007-10-25       Impact factor: 16.687

8.  Shaken, not stirred: mechanical stress testing of an IgG1 antibody.

Authors:  Sylvia Kiese; Astrid Papppenberger; Wolfgang Friess; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

9.  Immunogenicity of aggregates of recombinant human growth hormone in mouse models.

Authors:  Amber Haynes Fradkin; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

Review 10.  A critical review of analytical methods for subvisible and visible particles.

Authors:  Linda O Narhi; Yijia Jiang; Shawn Cao; Kalman Benedek; Deborah Shnek
Journal:  Curr Pharm Biotechnol       Date:  2009-06       Impact factor: 2.837

View more
  74 in total

1.  Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc.

Authors:  Ramil F Latypov; Sabine Hogan; Hollis Lau; Himanshu Gadgil; Dingjiang Liu
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

2.  Structure and function of purified monoclonal antibody dimers induced by different stress conditions.

Authors:  Rajsekhar Paul; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Hermann Beck; Alexandre Briguet; Volker Schnaible; Thomas Buckel; Sabine Boeckle
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

3.  Flow imaging microscopy for protein particle analysis--a comparative evaluation of four different analytical instruments.

Authors:  Sarah Zölls; Daniel Weinbuch; Michael Wiggenhorn; Gerhard Winter; Wolfgang Friess; Wim Jiskoot; Andrea Hawe
Journal:  AAPS J       Date:  2013-08-31       Impact factor: 4.009

Review 4.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

Review 5.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

6.  Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions.

Authors:  Austin L Daniels; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2018-02-01       Impact factor: 3.534

7.  Measurement of Average Aggregate Density by Sedimentation and Brownian Motion Analysis.

Authors:  Richard E Cavicchi; Jason King; Dean C Ripple
Journal:  J Pharm Sci       Date:  2018-02-01       Impact factor: 3.534

8.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors:  Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-01-22       Impact factor: 3.534

9.  Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.

Authors:  Cavan Kalonia; Ozan S Kumru; Jae Hyun Kim; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-10-09       Impact factor: 3.534

Review 10.  Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Jake Pawlowski; Guanbo Wang
Journal:  J Pharm Biomed Anal       Date:  2020-02-12       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.